Managing Type 2 Diabetes in Marginalized Populations

Dr. Greg Bondy, MD, FRCPC
Clinical Associate Professor of Medicine and Pathology at the University of British Columbia (UBC)
Director of the IDC Metabolic Clinic and Associate Director of the Healthy Heart Prevention Clinic, St. Paul’s Hospital

Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025